M Hobzova, J Prasko, J Vanek, M Ociskova… - Neuroendocrinol Lett, 2017 - nel.edu
OBJECTIVE: Obstructive sleep apnea (OSA), is described as intermittent interruptions or reductions in airflow which are initiated by an incomplete or complete collapse of the upper …
KL Lavallee, XC Zhang, S Schneider… - Frontiers in …, 2021 - frontiersin.org
The present study examines the relationship between obesity and mental health using longitudinal data. Participants with data at baseline and one-year follow-up were included …
I Bouloukaki, C Mermigkis, S Michelakis… - Journal of Clinical …, 2018 - jcsm.aasm.org
Study Objectives: To assess the role of different levels of adherence and long-term effects of positive airway pressure (PAP) therapy on gas exchange, sleepiness, quality of life …
Study Objectives: Both obesity and airways disease can lead to chronic hypercapnic respiratory failure, which can be managed with positive airway pressure (PAP) therapy. The …
HA Rantala, S Leivo-Korpela… - … of Palliative Care, 2022 - journals.sagepub.com
Objectives: Patients with chronic respiratory insufficiency suffer from advanced disease, but their overall symptom burden is poorly described. We evaluated the symptoms and …
Abstract Study Objective Neurophysiological activity during wake and sleep states in obesity hypoventilation (OHS) and its relationship with neurocognitive function is not well …
A Karkala, A Baxevanidis, A Chasiotou, D Siopi… - Sleep and …, 2024 - Springer
Purpose Obstructive Sleep Apnea Syndrome (OSAS) and Obesity Hypoventilation Syndrome (OHS) share common causal factors and comorbidities but may have a variable …
A Nayebi, Z Naderi, R Sami, M Hashemi… - Advanced Biomedical …, 2022 - journals.lww.com
Background: Obesity hypoventilation syndrome (OHS) is associated with increased mechanical load on respiratory system. Here, we aimed to investigate and evaluate the …
J Vaněk - Psychiatrie pro praxi, 2018 - psychiatriepropraxi.cz
Obstructive sleep apnea (OSA) is the most common sleep-related breathing disorder with a lifetime prevalence of 2–14% in the adult population. The hallmark of the disease are …